SCHEMBL1970330

SCHEMBL1970330

Cc1ccc(S(=O)(=O)n2ccc3ccc(Cl)cc32)cc1N

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 15/20 0.52
PPARG P37231 1/20 0.46
PPARD Q03181 1/20 0.46
PPARA Q07869 1/20 0.46
CYP3A4 P08684 3/20 0.45
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RAPGEF4 Q8WZA2 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CPT2 P23786 1/20 0.42
CPT1A P50416 1/20 0.42
CPT1B Q92523 1/20 0.42
DRD2 P14416 1/20 0.42
HTR2A P28223 1/20 0.42
HTR7 P34969 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1975643 0.85 HTR6 (0.52) HTR6PPARGPPARDPPARACYP3A4
SCHEMBL2274765 0.83 HTR6 (0.65) HTR6MEN1KMT2AMAPTHTT
SCHEMBL1306928 0.82 HTR6 (0.54) HTR6PPARGPPARDPPARACYP3A4
SCHEMBL1981284 0.79 PPARG (0.53) HTR6PPARGPPARDPPARAMEN1
SCHEMBL3662740 0.77 PPARG (0.52) HTR6PPARGPPARDPPARAMEN1
SCHEMBL424532 0.76 HTR6 (0.68) HTR6PPARGPPARDPPARACYP3A4
SCHEMBL29365890 0.76 HTR6 (0.68) HTR6PPARGPPARDPPARACYP3A4
SCHEMBL1971805 0.76 HTR6 (0.48) HTR6PPARGPPARDPPARACYP3A4
SCHEMBL2007388 0.76 HTR6 (0.44) HTR6PPARGPPARDPPARACYP3A4
SCHEMBL1977816 0.75 HTR6 (0.48) HTR6PPARGPPARDPPARACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003670-B2 Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-08-23 US disclosed
EP-2155674-B1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LTD (IN) 2011-06-22 EP disclosed
US-20100087484-A1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2010-04-08 US disclosed
EP-2155674-A1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS Suven Life Sciences Limited (IN) 2010-02-24 EP disclosed
WO-2008136017-A1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2008-11-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087484-A1 AMINOALKOXY ARYL SULFONAMIDE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS HTR6, HTR5A, HTR1B HTR6 1/4885PPARG 1121/4885PPARD 1515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.